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Spaceflight Physiology 
Microgravity Effects on the Human Body 
•One of largest tissues in the human body, 
although largely in fluid state. 
 
•Consists primarily of white blood cells 
(WBCs) located in lymph nodes and the 
peripheral blood.  
THE IMMUNE SYSTEM 
 
•Responsible for protection against viral 
and bacterial infection, latent viral 
reactivation, tumor surveillance, wound 
healing, etc. 
 
•Dysregulation can result in increased 
infection rate, malignancy, autoimmunity, 
allergy, etc. 
 
Immune System Disease 
Deficiency 
Dysregulation 
Infection 
Hyper? 
Hypo? 
Specific 
Clinical 
Risks 
Stress 
Acute 
Chronic 
Fight or Flight 
ANS/Sympathetic NS 
Catecholamines 
Shorter space flight? 
Anxiety, worry (rest/digest) 
HPA 
Corticosteroids 
Longer space flight? 
↑NK cytotoxicity 
↓ T regulatory cells 
↓NK, CTL function 
↓ IL-2, IFN 
↓ DTH 
↑ IL-4 
↑Ab levels 
↑ Illness severity 
Th1  -  Immunity to intracellular 
pathogens, viruses 
 
Normal Function 
•Cell Mediated ‘Inflammatory’ Response 
•Fight intracellular pathogens (viruses) 
•Control DTH response to skin viral/bacterial 
antigens 
•Fight tumor formation 
•Phagocyte dependent inflammation   
 
Disease correlations:  
Rheumatoid arthritis 
organ specific immune disorders 
Chohn’s disease 
Sarcoidosis 
Acute allograft rejection 
Unexplained recurrent abortions 
Multiple sclerosis 
Th2  -  Antibody response to 
extracellular pathogens, parasites 
 
Normal Function 
•Humoral (Antibody) Responses 
•‘Anti-Inflammatory Response  
 
 
 
 
Disease correlations:  
Rapid progression of HIV to AIDS 
Chronic graft vs. host disease 
Systemic autoimmune diseases 
Atopic asthma 
Scleroderma 
Serum lupus erythematosus 
Chronic allergies/sensitization 
Atopic dermatitis 
 
•Genetics 
•Pathogen 
•Local APC Ck environment 
(NK=IFN;, DC:IL-10, Mast:IL-4) 
•Antigen dose/route 
CYTOKINE NETWORK and DISEASE 


Spaceflight Analogs 
SPACEFLIGHT GROUND ANALOGS 
•Validation of monitoring strategy, 
countermeasures 
 
•Determination of mechanism 
 
•Validation of flight hardware 
 
FLIGHT-RELATED 
-Radiation 
-Microgravity 
 
 
MISSION-ASSOCIATED 
-Physiological stress 
-Confinement 
-Prolonged isolation 
-Altered microbial environment 
-Altered nutrition 
-Disrupted circadian rhythms 
 
WHAT CAUSES IMMUNE CHANGES 
DURING SPACEFLIGHT? 
-Simulate some aspects of spaceflight on Earth for research 
purposes. 
 
-Routinely used for human physiology research, development of a 
monitoring strategy, investigation of mechanism, countermeasures 
development/validation.  
 
-Useful considering the microgravity restrictions on flight hardware. 
What are GROUND BASED SPACEFLIGHT ANALOGS? 
Extended head-down bed rest MARS-500  (IBMP – Moscow) 
NEEMO Aquarius Station Antarctica winter over Haughton-Mars Project 
Closed Chamber Confinement 
(Human) Ground-based Space Flight Analogs 
An analog which simulates (or actual) mission-deployment, associated risk, adverse 
environment, isolation, psychological/physiological stress, disrupted circadian rhythms, 
etc. 
Best Analogs for SAID 
Bed Rest + Artificial Gravity 
Bed Rest + Artificial 
Launch/Landing Stress 
MODELED 
MICROGRAVITY 
1xG CONTROL 
Red:  Actin localization 
Green:  Microtubules/MTOC 
-Mayra Nelman-Gonzalez/JSC 
NEEMO Aquarius Station 
(Key Largo - Florida) 

Haughton-Mars Project 
(High Canadian Arctic – Devon Island) 
Haughton Crater 
HMP BASE CAMP 
FMARS HAB 
Antarctica 
Antarctica is the highest, driest, windiest, emptiest, coldest place on earth.  An ice 
sheet covers all but 2.4 percent of Antarctica's 14 million square kilometers. 
 
At its thickest point the ice sheet is 4,776 meters deep and averages 2, 160 meters 
thick. This is 90 percent of all the world's ice and it is 70 percent of all the world's 
fresh water.  
 
The mean annual temperature at the South Pole is minus 56 degrees F. During the 
Austral Summer, temperatures at McMurdo base, on the Ross Sea, may get as 
high as 40 degrees F, while at the South Pole, at the Amundsen- Scott station, 
temperatures may reach 0 degrees F. 
 
The area below 60 
degrees south enjoys 
one long day and one 
long night each year. 
The sun sets in March 
and rises in October. 
At the dawn of the 1900s, Antarctica remained the only continent untouched by 
humans.   In 1895, the 6th International Geographical Congress declared that 
Antarctica’s ice-choked seas and frozen peaks were the next frontier for scientific 
discovery, ushering in what has come to be known as the Heroic Age of Antarctic 
Exploration. 
 
The Antarctic continent wasn't even actually seen until 1820.  
 
No man set foot in Antarctica until 1895. The first human landing there is claimed 
by Henryk Bull, with a party from a whaling ship. They landed at Cape Adare .   It 
was 1935 before the first woman set foot there. Her name was Catherine 
Mikkelson, and she was the wife of a Norwegian whaling captain.  
 
Amundsen and crew at the South Pole, December 14, 1911 
The South Pole was first reached 
by a Norwegian named Roald 
Amundsen in 1911, and shortly 
after by British explorer Robert 
Scott. 
 
Eskimos and polar bears are found in the ARCTIC, not the Antarctic. 
 
All warm-blooded animals living on and around Antarctica--whales, seals, sea 
birds, penguins--rely on thick layers of blubber to insulate them from the cold.  
 
Plants grow in Antarctica in ice-free regions (only about 2 percent of the continent 
is ice-free). Lichens and moss grow in any favorable niche.  
 
There are 21 species of penguins in Antarctica, including Emperor, Rockhopper 
and Adelie. 
 
 
There are actually more petrels 
than there are penguins! 
Petrels include albatrosses, 
fulmars, prions, shearwaters, 
storm petrels, diving petrels 
and Gadfly petrels. Other birds 
that live in or breed in 
Antarctica include cormorants, 
gulls, and skuas 
Nimrod Expedition 1907-1909:  112 miles from Pole, 
first ascent of Mt. Erebus, first plot of magnetic pole 
 
Endurance Expedition 1914-1916:  Planned trans 
Antarctic traverse. 
 
 
Ernest Shackleton 





Antarctica covers the South Pole 
Midnight at the pole 21st December Midday at the pole 21
st June 
The Living Earth, Inc. copyright 2006 
South 
Pole X 
South 
America 
Africa 
Australia and NZ 
X 
The commonest way to get to Antarctica is still by ship. This means crossing 
the “Drake‟s Passage”, the narrow band of sea between Cape Horn and the 
Antarctic Peninsula. It is the roughest sea on Earth.  
Increasing numbers of people now arrive in Antarctica by air. Ice runways are 
becoming more and more common and this is an increasingly common form of 
transport for those on scientific bases. The passengers can be dropped off in South 
America or Australia for onward transport rather than spending weeks on board ships 
as was the case until relatively recently. 
As the winter approaches, the only people left behind in Antarctica are 
scientists and support staff on research stations. About 1000 people in an 
area 1.5 times larger than the USA. Sea-ice doubles the area of Antarctica at this 
time and flights are very rarely attempted due to the darkness and weather 
conditions. This is Signy station (UK). 
Antarctic bases old and new. In the foreground on Hut-Point McMurdo Sound 
is Scott‟s 1904 hut from the Discovery expedition that housed 25 men, in the 
background is the modern McMurdo base that houses about 250 people in the 
winter and around 1000 in the summer – it is far and away the largest Antarctic 
Base. 
The interior of Scott‟s hut is preserved like a time capsule. A combination of 
lack of visitors, cold temperatures and great respect shown by the few visitors 
there have been means that many items are exactly as they were when left 
over 100 years ago. 
Amundsen-Scott Base at the South Pole. This base houses 75 over the 
winter and 250 in the summer. It is the third base in this location, the previous 
two were buried by accumulating snow and ice. Like other modern base 
designs built on ice, this is elevated on legs and can be raised to stay clear 
when the accumulation threatens to take over. 
Dumont d'Urville (France)  
Mario Zucchelli Station at Terra 
Nova Bay (Italy) 
Neymayer III Station (Germany) 
Casey Base(Australia) 
Science in Antarctica. Bases in Antarctica exist so that science can take 
place, there are a great number of different projects from the small to the large. 
This is a 10m telescope and laboratory at the South Pole. 
A huge silence. As the temperature falls, so any water vapour in the air freezes and 
falls out. You can see as far as there‟s anything to see. From this point it is possible 
to see over 100 miles (160km) in all directions. With no wind, the entire area is 
motionless and totally silent. 
Standing next to even a 
small berg can be an un-
nerving experience.  
If the sun is out, the 
different colours warm up 
at different rates, clear 
regions can act like a lens 
warming up the interior.  
The result is all kinds of 
creaks and bangs.  
Add to this the sea-ice 
around it creaking as the 
tide rises or falls and it 
becomes an uncomfortable  
place to be. 
There‟s also the fact that 
you‟re on ice not very thick 
and there‟s 8-10 times 
more ice below your feet 
than you can see. 
Antarctic land transport. Many vehicles are tracked including all that go away 
from the bases, wheeled transport is used in and around bases where 
conditions are predictable. 
A pair of adélies all clean and glistening after being freshly laundered by the 
sea take a short break on their way to the breeding colony. These only had a few 
miles to walk across the frozen sea. Sometimes if the ice persists, they can have 
10‟s of miles to go. Must be so much worse when you only have such little legs. 
The large icy step is called 
an “ice foot” it completely 
surrounds coasts at the 
end of winter. As the tide 
rises and falls, so it leaves a 
layer of ice each time which 
builds up to be left as a 
large step  when the 
attached sea-ice breaks up 
and floats away. 
These penguins are 
returning from a fishing trip 
to find the tide has gone out 
and they can‟t get back to 
the shore, so they wander 
up and down the bottom of 
the ice foot until the tide 
comes back in and can float 
them back up to the right 
level. 
Despite their small size and apparent fragility, snow petrels are quite capable 
of toughing it out on the ice with no other shelter than putting their head under 
their wing. Here at -20°C and 15-20 knot winds. 
Displaying skua. Display is to, or for a mate or other skuas to establish a 
territory. Sometimes the birds do this as a pair, it is quite an impressive sight and 
the squawking can be heard some considerable distance away. Skuas will also do 
this if their nest is being approached by an unwanted visitor. 
Southern Elephant Seals were one of the main targets for Antarctic sealers. 
They were hunted for their blubber. Blubber is a “blanket” of fat just beneath the 
skin.  They need this as they are warm blooded mammals and need to keep a 
normal body temperature despite hours in seas below freezing that would kill most 
mammals within minutes. 
Concordia Station 


Environmental Factors Difficult travel in/out 
Extreme isolation, even greater than ISS 
Altitude 3200m (10,500 ft) 
Air pressure 645hPa (mbar) 
12-13 Vol% of O2  
 Lack of CO2 in air 
Higher ionization in air (increases oxidative 
metabolism) 
 
•Relative humidity 3-5% 
•Snowfall ~1cm/yr 
•High winds 
•Elevated UV exposure (summer), UV 
deficiency (winter) 
•Mean winter temperature -60 C (-72 F) 
•Mean summer temperature -30 C (-22 F) 
•Disrupted circadian rhythms.   
chronic hypobaric hypoxia 
Human Factors 
•Isolation, confinement for prolonged 
duration 
•Limited communication capability with 
outside world (more isolated than ISS!) 
•International crew, multiple languages 
•Realistic station lifestyle 
•Sleep/wake cycles disrupted 
•Actual extreme environment 
deployment w/ associated risks (not a 
mission analog!) 
•Winter over crew: 12 
•Summer crew: ~50 

CHOICE Study 
CONCORDIA STATION, DOME C, ANTARCTICA AS A GROUND-BASED 
ANALOG FOR SPACEFLIGHT/PLANETARY EXPLORATION: 
The CHOICE* Immunology Study 
Brian Crucian, Satish Mehta, Raymond Stowe, Alexander Chouker, Alex Salam, Ales 
Rybka, Heather Quiriarte, Duane Pierson and Clarence Sams 
Final Data; NASA Assays - February, 2012 
*Consequences of both long-term confinement (“Confinement Stress”) and hypobaric 
hypoxia (“Hypoxic Stress”) on Immunity (“Immune-Modulation/Suppression”) in the 
Antarctic CONCORDIA Environment.  
Effects of Space 
Flight 
Immune System 
Changes 
Adverse clinical 
outcomes 
(Latent Viral Reactivation) 
(Status and Function) 
NASA Paradigm 
CHOICE-Study:  Consequences of 
both long-term confinement 
(“Confinement Stress”) and 
hypobaric hypoxia (“Hypoxic 
Stress”) on Immunity (“Immune-
Modulation/Suppression”) in the 
Antarctic CONCORDIA 
Environment.     
BLOOD ASSAYS
Pre, post 
sampling
In- 
sampling Details NASA Lab
Comprehensive immunophenotype WB (see panel) Immune
Intracellular cytokine profiles (T cell) WB PMA+ION, LPS Immune
T cell function WB CD3/CD28, A+B Immune
Secreted cytokine profiles WB Th1/Th2, Inflam. Immune
Viral DNA - PBMC WB EBV Mcgn
Circulating viral-specific T cells WB EBV, CMV Mcgn
Viral-specific T cell function WB EBV, CMV Mcgn
Viral antibodies titers Plasma Plasma EBV, CMV Mcgn
Viral antibodies titers Plasma Plasma VZV Micro
Plasma stress hormones Plasma Plasma cortisol Mcgn
SALIVA ASSAYS
Saliva stress hormones, Diurnal Dry Saliva Dry Saliva cortisol, DHEA Micro
Viral DNA by PCR Liquid Saliva Liquid Saliva CMV*, EBV, VZV Micro
URINE ASSAYS
Viral DNA by PCR 24hr. URINE 24hr. URINE CMV Micro
Urine stress hormones 24hr. URINE 24hr. URINE cortisol*, cat.* Micro
Assays 
BLOOD ASSAYS
Pre, post 
sampling
In- 
sampling Details NASA Lab
Comprehensive immunophenotype WB (see panel) Immune
Intracellular cytokine profiles (T cell) WB PMA+ION, LPS Immune
T cell function WB CD3/CD28, A+B Immune
Secreted cytokine profiles WB Th1/Th2, Inflam. Immune
Viral DNA - PBMC WB EBV Mcgn
Circulating viral-specific T cells WB EBV, CMV Mcgn
Viral-specific T cell function WB EBV, CMV Mcgn
Viral antibodies titers Plasma Plasma EBV, CMV Mcgn
Viral antibodies titers Plasma Plasma VZV Micro
Plasma stress hormones Plasma Plasma cortisol Mcgn
SALIVA ASSAYS
Saliva stress hormones, Diurnal Dry Saliva Dry Saliva cortisol, DHEA Micro
Viral DNA by PCR Liquid Saliva Liquid Saliva CMV*, EBV, VZV Micro
URINE ASSAYS
Viral DNA by PCR 24hr. URINE 24hr. URINE CMV Micro
Urine stress hormones 24hr. URINE 24hr. URINE cortisol*, cat.* Micro
JAN FEB MAR APR MAY JUNE JULY AUG SEPT OCT
CONCORDIAPre Post
Early
Overwinter 
Late R+30L-60
Overwinter Overwinter Overwinter 
Sampling 
ASSAY SAMPLE* Pre/Post Overwinter
Mitogen/
Specific Analyte NASA Lab
Comprehensive immunophenotype Whole blood X (see panel) Immune
T cell intracellular cytokine profiles Whole blood X PMA+ION, LPS Immune
T cell function/24hr early blastogenesis Whole blood X CD3/CD28, A+B Immune
Secreted cytokine profiles/48h stimulation Whole blood X Th1/Th2, Inflam. Immune
Viral DNA - PBMC Whole blood X EBV Mcgn
Circulating viral-specific T cells Whole blood X EBV, CMV Mcgn
Viral-specific T cell function Whole blood X EBV, CMV Mcgn
Viral antibodies titers Plasma X X EBV, CMV Mcgn
Viral antibodies titers Plasma X X VZV Micro
Plasma stress hormones Plasma X X cortisol Mcgn
Saliva stress hormones, Diurnal Dry saliva X X cortisol, DHEA Micro
Viral DNA by PCR Liquid saliva X X CMV*, EBV, VZV Micro
Viral DNA by PCR 24h Urine X X CMV Micro
Urine stress hormones 24h Urine X X cortisol*, cat.* Micro
*Pre, post:   5.0 ml heparin whole blood, 1.0 ml saliva, dry saliva book, 10 ml of 24 hr. urine
Overwinter:  0.5 to 1.0  ml frozen plasma, 1.0 ml frozen saliva, dry saliva book, 10 ml of frozen 24 hr. urine
Subjects/Logistics 
2008/2009 Summer Transition 
 
 
 
2009 Overwinter 
 
 
 
2009/2010 Summer Transition 
 
 
 
2010 Overwinter 
 
 
 
2010/2011 Summer Transition 
n=6 
n=9 
L-60 +2Wk Jan Feb Mar Apr May June July Aug Sept Oct Nov +9Mo R+30
A X X X X X X X
B X X X X X X X
C X X X X X X X
D X X X X X X X
E X X X X X X X
F X X X X X X
G X X C, V X C, V X X
H X Subject withdrawn
J X Subject withdrawn
K X X C, V X C, V X X
L X X C, V X C, V X X
M X X C, V X C, V X X
N X X C, V X C, V X X
O X X C, V X C, V X X
P X X C, V X C, V X X
J* X C, V X C, V X X
*Subject added after deployment; no baseline
X Primary sampling:  Phenotype, T cell function, cytokine profiles, viral immunity, viral reactivation.
C Cytokine profiles (culture supernatant)
V Latent viral reactivation (saliva sample)
W
O
 2
0
0
9
W
O
 2
0
1
0
        Deployed to Concordia Station
Overwinter Isolation
Table:  Sampling schedule for CHOICE study.   Baseline samples (L-60 and R+30) were collected and processed 
in Europe before/after deployment.  Summer transition samples (+2wk, +9mo) were processed at Concordia 
Station during the high-habitation summer transition period.  All other samples were were processed during the 
high isolation overwinter period.  Not all assays were performed at each timepoint, due to technical or sampling 
constraints.  
Unplanned „bonus‟ mid-winter testing 
•Partec cytometer plan:  bring in/out for support of each early/late timepoint. 
•Revised to leave during winter over, with Dr. Salam to process samples. 
•Reagents issues 
•Consumable supply issues 
•Data/training issues 
•Additional assays as training/reagents/consumables allowed, phenotype, cell cultures. 
•First run:  deployment month #2.  Samples collected at DC,  data acquired at DC, data 
emailed to JSC, analysis performed at JSC.    
Overwinter Data:  Phenotype 
NAÏVE 
MEMORY 
Granulocytes 52 ± 1.7 44 ± 1.6* 31 ± 3.3* 37 ± 2.3* 44 ± 2.1* 46 ± 3.0* 63 ± 2.1
Lymphocytes 40 ± 1.8 47 ± 2.2* 49 ± 3.3* 50 ± 3.0* 45 ± 2.6 44 ± 2.8 32 ± 3.4
Monocytes 5.0 ± 0.4 5.0 ± 0.4 10 ± 0.8* 7.0 ± 0.6* 5.0 ± 0.8 5.0 ± 0.5 3.0 ± 0.4
T Cells 67 ± 1.9 60 ± 1.9* 65 ± 1.3 55 ± 2.6* 54 ± 2.0* 56 ± 2.2* 77 ± 2.2
B Cells 7 ± 1.9 13 ± 1.8* 12 ± 3.4* 11 ± 1.3* 19 ± 3.2* 13 ± 1.2* 12 ± 1.6
NK Cells 6 ± 1.6 9 ± 2.2 10 ± 2.2* 12 ± 2.4 5 ± 1.2 11 ± 1.2 18 ± 2.2
CD4+ T Cells 59 ± 2.4 55 ± 3.0* 50 ± 5.4* 51 ± 3.0* 50 ± 2.9* 53 ± 1.7* 61 ± 2.8
CD8+ T Cells 33 ± 2.1 32 ± 1.4 29 ± 2.2 26 ± 1.3* 25 ± 1.9* 30 ± 1.6 27 ± 2.2
Bulk Memory CD4+ 54 ± 3.7 59 ± 3.2 56 ± 7.9 59 ± 4.3 62 ± 2.7* 68 ± 3.4* 49 ± 6.1
Bulk Memory CD8+ 37 ± 2.8 59 ± 5.2* 41 ± 7.5 58 ± 5.9* 59 ± 5.3* 74 ± 2* 32 ± 5.2
CD8: Naïve/ctx 85 ± 2.8 49 ± 5.5* 65 ± 4.3* 57 ± 4.4* 62 ± 4.4* 53 ± 5.5* 92 ± 2.5
CD8: Senescent 12 ± 2.7 35 ± 4.3* 24 ± 4.4* 26 ± 3.7* 21 ± 4.2 27 ± 4.7* 7 ± 2.1
CD8: True Naïve 38 ± 7.0 35 ± 4.1 27 ± 5.6 31 ± 2.5 35 ± 3.8 28 ± 2.1 21 ± 5.5
Central memory 6 ± 1.5 10 ± 0.9 5 ± 1.7 13 ± 3.0 10 ± 1.3 13 ± 1.6 34 ± 6.0
Effector Memory 39 ± 5.1 32 ± 3.8* 37 ± 6.5 33 ± 3.9 32 ± 3.1* 35 ± 2.9 38 ± 5.2
Term. Differentiated 17 ± 2.4 23 ± 1.9 31 ± 6.7 22 ± 2.0 24 ± 1.4* 25 ± 1.4 7 ± 1.6
CD4/CD69 1 ± 0.2 6 ± 0.8* 1 ± 0.4 2 ± 0.3 2 ± 0.5 2 ± 0.3 0 ± 0.1
CD8/CD69 2 ± 0.3 9 ± 1.5* 3 ± 0.3 3 ± 0.5 3 ± 0.7 3 ± 0.8 2 ± 0.4
CD4/HLA-DR 2 ± 0.5 3 ± 0.7 3 ± 0.3 2 ± 0.4 1 ± 0.2 1 ± 0.2 2 ± 0.2
CD8/HLA-DR 3 ± 1.0 5 ± 1.1* 2 ± 0.7 2 ± 0.5 1 ± 0.2 1 ± 0.3 3 ± 0.8
Deployment Phase
R+60Baseline +2 Wk +2 Mo +4 Mo +6 Mo +9 Mo
Table 1:  Mean peripheral leukocyte distribution for Concordia overwinter subjects.  Data are expressed as 
mean percentage ± SEM.  * indicates statistically significant difference p≤0.05.   For this assay n=14, except
+2wk and R+60 timepoints (n=6 and 5, respectively).
KINETICS OF T CELL ACTIVATION
T 0:00 Ligand-receptor binding
0-5 sec Membranes increase permeablity to ions
Shifts in ions from one intracellular compartment to another
Changes in membrane potential
Changes in intracellular pH
0-5 min Changes of state in membrane lipids and proteins
Activation of adenylate cyclase, ATPase, and other membrane-
associated enzymes
Changes in cyclic nucleotide concentractions
Changes in receptor distribution and mobity occur
Adhension molecule conformational changes
T +30 min
Coalescence of patched receptors into cap at one pole of the cell 
(dependant on contractioin of cytoskeletal microfilaments, ATP 
energy source)
T +6-12hr Expression of CD69 on T cell surface
T +24 hr Secretion of IL-2, cell  surface epxression of IL-2 receptor (CD25)
Upregulation of CD40L
IL-2 binds to IL-2r (autocrine activation)
CD40L binds to CD40 on APC, upregulating CD86/CD80
APC CD86/80 binds to CD28 on T cell surface, results in additional 
cytokine expression, expression of BCL-x (anti-apoptosis, 
proliferation
36-72 hr DNA synthetic activity
Epression of HLA-DR
3-4 days Blast transformation
Differentiation into Th1/Th2/Th17 cell based on factors such as 
antigen dosage, local cytokine environment, other costimulatory 
molecules, APC involvement
FUNCTIONAL IMMUNE 
ASSAYS 
Remove cells from body 
Stimulate cells during culture, 
mimicking a natural immune response 
Observe characteristics of normal 
immune activation: 
•Signal transduction 
•Morphological changes 
•Expression of cellular activation 
markers 
•Production of cytokines 
•Chemotaxis 
•Cytotoxicity 
•Proliferation 
• Remove cells from body 
• Stimulate cells with mitogens during 
culture, mimics an in-vivo immune 
response 
T cell function 
Cytokine Secretion 
Proliferation 
Kinetics of T Cell Activation 
T Cell Function vs. Disease 
T Cell Mitogen – Mechanism of Action 
CD3 
CD28 
Y 
Y 
Anti-CD3/CD28 
SEA+SEB 
CD25+ 
Unactivated 
1 hr ~24 hr 
EM image obtained from Institute Pasteur website 
C
D
6
9
+
 
B7 
CD28 
Mitogen
SEA+SEB CD4/69+ 10 ± 1.2 21 ± 3.6* 19 ± 2.4 10 ± 2.7
CD4/69/25+ 2 ± 0.3 14 ± 3.8 7 ± 1.2 6 ± 1.3
CD8/69+ 9 ± 1.4 25 ± 5.3 30 ± 3.9 15 ± 3.8
CD8/69/25+ 2 ± 0.5 12 ± 4.1 7 ± 1.4 6 ± 1.5
anti-CD3/CD28 CD4/69+ 48 ± 1.1 70 ± 0.6 52 ± 13.7 43 ± 10.5
CD4/69/25+ 37 ± 1.2 49 ± 3.7 30 ± 11.6 26 ± 6.7
CD8/69+ 51 ± 2.3 72 ± 5.9 42 ± 11.9 46 ± 10.2
CD8/69/25+ 29 ± 2.7 40 ± 4.9 23 ± 11.1 19 ± 4.8
R+60Baseline +2 Wk +9 Mo
Deployment Phase
Table 2:  Mean T cell function/early blastogenesis for Concordia overwinter subjects following 
mitogenic stimulation for 24 hours with the indicated mitogen.  Data are expressed as mean 
percent cells stimulated to produce the indicated activation markers (CD69 and/or CD25) ±
SEM.  * indicates statistically significant difference p≤0.05.  For the SEA/SEB assay n=6, for the 
CD3/28 assay, n=4.
Overwinter Data – T cell Function 
2009/10 Summer Transition period – Incidence Rates 
 
(mid-November to mid-January) 
 
•Approx. 50% of summer participants contacted 
infectious disease 
 
•Historically, extremely high incidence rate 
 
•Three periods of epidemic viral infections: 
 
   Period 1:  Flu-like (mid-Nov. to mid-Dec.) 
 
   Period 2:  Rhinoparyngitis (mid-Dec. to early 
Jan.) 
 
   Period 3:  Gastro-enteritis (late-Dec. to early 
Jan.) 
 
 
-Data from Concordia Station, Chief Medical Officer 
Overwinter Data:  Secreted Cytokine Profiles 
Mitogen
CD3/CD28 IFNg 74 ± 22.1 58 ± 21.1 100 ± 55.6 104 ± 27.9 116 ± 23.3 138 ± 24.7 59 ± 40.4
TNFa 20 ± 6.2 24 ± 8.9 24 ± 12.5 13 ± 2.0 15 ± 3.7 21 ± 4.3 9 ± 5.9
IL-10 6 ± 0.3 16 ± 3.7 5 ± 1.8 8 ± 1.0 8 ± 2.1 9 ± 3.3 3 ± 0.7
IL-4 0 ± 0.1 0 ± 0.0 0 ± 0.1 0 ± 0.1 0 ± 0.2 0 ± 0.1 0 ± 0.1
IL-5 4 ± 1.7 2 ± 1.2 7 ± 5.9 8 ± 3.3 9 ± 5.9 5 ± 2.5 3 ± 2.9
IL-2 32 ± 12.2 4 ± 1.3 64 ± 33.7 33 ± 11.3 33 ± 19.2 43 ± 10.8 12 ± 8.0
IFNg 287 ± 12.0 281 ± 16.2 251 ± 17.3 247 ± 11.6 248 ± 17.6 238 ± 12.9* 220 ± 16.2*
TNFa 51 ± 6.4 82 ± 12.7* 105 ± 15.7* 127 ± 18.7* 98 ± 12.3* 111 ± 16.2* 35 ± 6.8*
IL-10 7 ± 1.5 19 ± 2.7 16 ± 2.7 21 ± 2.4 19 ± 4.0 20 ± 2.9 5 ± 1.1
IL-4 3 ± 0.7 5 ± 1.1* 4 ± 0.7* 5 ± 1.1* 5 ± 0.9* 6 ± 1.1* 2 ± 0.3
IL-5 15 ± 2.8 19 ± 3.4 17 ± 2.9 19 ± 3.2* 18 ± 3.3 20 ± 2.8 11 ± 2.6
IL-2 689 ± 26.7 701 ± 44.6 725 ± 34.7 764 ± 11.2* 764 ± 13.1* 736 ± 9.3* 526 ± 52.7*
LPS TNFa 9 ± 1.6 20 ± 4.1* 17 ± 3.8* 18 ± 3.6* 21 ± 4.6* 17 ± 4.0* 12 ± 2.2
IL-10 14 ± 1.2 27 ± 4.7* 43 ± 7.3* 37 ± 3.4* 37 ± 3.2* 42 ± 7.6* 6 ± 2.1
IL-6 432 ± 25.9 431 ± 34.8 498 ± 32.6 494 ± 25.8 506 ± 29.2 477 ± 24.8 232 ± 41.5
IL-1b 51 ± 4.8 95 ± 18.3* 50 ± 6.7 54 ± 8.4 57 ± 6.7 39 ± 7.5 110 ± 16.3
IL-8 610 ± 16.2 583 ± 37.8 529 ± 40.3 591 ± 21.8 600 ± 30.3 577 ± 29.0 408 ± 68.2
Deployment Phase
PMA/
Ionomycin
Feb-Mar Apr-May Jun-Jul Aug-Sep +9 MoBaseline +2 Wk
Table 3:  Mean intracellular and secreted cytokine levels for Concordia overwinter subjects following 
mitogenic stimulation for 48 hours with the indicated mitogen.  Data are expressed as mean 
fluorescence intensity (correlates with concentration) ± SEM.  * indicates statistically significant 
difference p≤0.05.  For the CD3/28 assay n=4, for the PMA/I assay n=14 except the Aug-Sept and 
R+60 timepoints (n=8 and 5, respectively),  for the LPS assay n=14 except the R+60 timepoint (n=5).
(A) Levels of virus-specific (EBV, CMV) CD8+ T-cells before and during the winter-
over period, and (B) Percentage of functional virus-specific T-cells before and during 
the winter-over period.   
Overwinter Data:  Viral Immunity 
Levels of antiviral antibodies [EBV-VCA (A), EBV-EA (B), and CMV (C)] and EBV 
DNA in peripheral blood (D) before and during the winter-over period.  
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Overwinter Data:  Viral Immunity 
Stress Hormone Levels 
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Stress Hormone Levels 
EBV and VZV shedding  in saliva during Concordia Study 
# of Subjects 
# of samples 
from 8 subjects 
Samples + for 
EBV 
Samples + for 
VZV 
        
8 184 35 (6) 25 (5) 
    19.20% 13.60% 
() denote number of subject shed virus 
Before 32 6; 19% 0 
After 16 2; 13% 0 
During 136 27; 20% 25; 18.4% 
In- Isolation After Before 
EBV DNA in the saliva of Concordia subjects before, during and after isolation 
(n=8).   6 of 8 subjects shed EBV at some point during the overwinter period. 
Overwinter Data:  Viral Reactivation 
VZV DNA in the saliva of Concordia subjects before, during and after isolation (n=8).   4 of 8 
subjects shed VZV at some point during the overwinter period. 
Overwinter Data:  Viral Reactivation 
During the early adaptation phase for the 2009 deployment (November the 8th 2008 to 
February the 8th 2009, 93 days ), 85 participants were at Concordia Station (excluding 
pilots and visits of <48hr).  During this period, approximately 50% of summer participants 
contacted infectious disease.  There were 62 new cases of infectious disease, concerning 
44 persons (51.76%).  30 persons were infected once, 11 were infected twice, 2 were 
infected three times and one was infected four times. Historically, these are extremely 
high incidence rates.  Three distinct periods of epidemic viral infections were observed: 
  
-Period 1:  Flu-like (mid-Nov. to mid-Dec.) 
-Period 2:  Rhinoparyngitis (mid-Dec. to early Jan.) 
-Period 3:  Gastro-enteritis (late-Dec. to early Jan.) 
  
Specific diagnoses during this period included: 
  
-influenzae : 29 cases  
-upper respiratory tract viral infection : 18 cases  
-gastro-enteritis : 10 cases  
-otitis : 2 cases  
-bladder infection : 2 cases  
-vaginal infection : 1 case  
Concordia Station – Clinical Incidence 
Concordia Station – Clinical Incidence 

Alterations in immune cell distribution and function, circadian 
misalignment, stress and latent viral reactivation appear to persist during 
Antarctic winterover at Concordia Station.   
 
Some of these changes are similar to those observed in Astronauts, 
either during or immediately following spaceflight.  Others are unique to 
the Concordia analog.  
 
Based on some initial immune data and environmental conditions, 
Concordia winterover may be an appropriate analog for some flight-
associated immune system changes and mission stress effects.    
 
An ongoing smaller control study at Neumayer III will address the 
influence of the hypoxic variable. 
‘CHOICE’ Conclusions 

 
During overwinter 
 
•Changes were observed in the peripheral blood leukocyte distribution consistent with 
immune mobilization, and similar to those observed during spaceflight.     
 
•Alterations in cytokine production profiles were observed during winterover that are 
distinct from those observed during spaceflight, but potentially consistent with those 
observed during persistent hypobaric hypoxia. 
 
•The reactivation of latent herpesviruses was observed during overwinter/isolation, that 
is consistently associated with dysregulation in immune function. 
 
  
Questions? 
Credit for some general Antarctica slides: Alan Light, Drummond 
Small, Mike Usher, Paul Ward and the European Space 
Agency/Alex Salam 
